Integrated Pharmacy Research and Practice

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "AI's Influence on Enhancing Pharmacy Services" in Integrated Pharmacy Research and Practice.

Over recent years, there has been a remarkable rise in the integration of artificial intelligence (AI) into the healthcare sectors, and the pharmacy sector is at the forefront of this transformation. This Article Collection aims to explore the impact of AI technologies on pharmacy services, including a comprehensive examination of innovative solutions, challenges, and advancements in this dynamic field. 

The importance of this Article Collection lies in its potential to revolutionize patient care and the operational aspects of pharmacies. AI holds the promise of optimizing the management of medications, reducing errors, and enhancing patient involvement. This Collection seeks to shed light on the transformative possibilities of AI, not only in improving the accuracy and efficiency of medication-related tasks but also in advancing the overall quality of healthcare provision. 

We invite contributions in research areas including, but not limited to, the following:

1. AI-powered medication dispensing and supply
2. Machine learning for personalized medication recommendations
3. Robotics in pharmacy settings
4. AI-enhanced patient counselling and education
5. Ethical and regulatory considerations in AI adoption within pharmacy services

All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisor for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

The deadline for submitting manuscripts is April 30th, 2024.

Please submit your manuscript on our website, quoting the promo code BJPQW to indicate that your submission is for consideration in this Article Collection. 

Guest Advisor

Name: Walid Al-Qerem, Associate Professor, Al-Zaytoonah University of Jordan

[email protected] 

Dr. Walid Al-Qerem obtained a PhD of Clinical Pharmacy from the University of Sunderland, UK. He is an associate professor at Al-Zaytoonah University of Jordan. Dr. Al-Qerem's research area covers improving the diagnosis and management of different diseases. This includes validation and formulation of spirometic equations to improve the diagnosis and management of many respiratory diseases including asthma and COPD, developing population specific growth charts to improve the tracking of children's growth, and to identify undiagnosed conditions and validate different instruments used to evaluate health-related quality of life and adherence to medication. Dr. Al-Qerem's research also covers the study of different variables that influence the outcomes of different diseases.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Telepharmacy Innovations: The Great Opportunity for Advancing Healthcare in the Digital Age" in Integrated Pharmacy Research and Practice.

Telepharmacy, an innovative branch of pharmacy that uses technology to provide services remotely, has emerged as a crucial response to changing healthcare needs in the digital age. Its importance lies in its ability to overcome geographic barriers and increase patient access to quality pharmaceutical services. As the world faces challenges such as the COVID-19 pandemic, telepharmacy has become a valuable resource for ensuring continuity of care and reducing the risk of exposure to the virus in healthcare settings. 

However, despite its growth and acceptance, telepharmacy remains an evolving field that requires continued research. Research is critical to better understand how to maximize its effectiveness, ensure patient safety, and address ethical and legal issues. In the future, potential lines of research could focus on improving communication technologies, integrating effectively with other healthcare professionals, identifying appropriate reimbursement models, and exploring how telepharmacy can be used in primary and specialty care settings. 

The new concept and model of pharmaceutical care presents telepharmacy as a great opportunity for permanent and real-time contact with the patient. 

Potential subtopics:

• Clinical Effectiveness Evaluation: Investigate the efficacy and safety of telepharmacy services compared to traditional pharmaceutical care in a variety of medical conditions. This could include collecting data on clinical outcomes, compliance rates, and patient satisfaction.
• Technology Integration: Study how the incorporation of emerging technologies, such as artificial intelligence and machine learning, can improve pharmaceutical decision making, drug-drug interaction identification, and treatment personalization.
• Data Security and Patient Privacy: Investigate advanced data security methods to protect patient privacy and ensure the integrity of health information transmitted through telepharmacy platforms.
• Reimbursement Models and Economic Sustainability: Explore sustainable reimbursement models for telepharmacy that incentivize the delivery of high-quality services and encourage pharmacist involvement in healthcare.
• Pharmacist Education and Training: Investigate how effective training can be provided to pharmacists to acquire the skills needed in the telepharmacy environment and keep up with technological advances.
• Access and Equity: Examine how telepharmacy can address disparities in access to pharmaceutical care, especially in rural and underserved areas.
• Multidisciplinary Integration: Investigate how more effective collaboration between pharmacists and other healthcare professionals can be achieved through telepharmacy for comprehensive patient care.
• Patient Experience: Study patient satisfaction and preferences in the use of telepharmacy and how to improve the overall patient experience.
• Regulation and Standards: Investigate how regulations and standards are evolving in response to the growth of telepharmacy and how they can be adapted to ensure patient safety and quality of care.
• Cost and Societal Benefit Assessment: Conduct cost-benefit analyses to determine the financial and societal impact of telepharmacy on the healthcare system as a whole.

All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisor for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

The deadline for submitting manuscripts is August 31st 2024.

Please submit your manuscript on our website, quoting the promo code KAIKS to indicate that your submission is for consideration in this Article Collection.

Guest Advisor

Ramón Alejandro Morillo Verdugo, Associate Professor, Hospital Pharmacy, University of Seville, AGS Sevilla Sur, Hospital de Valme

[email protected]

Dr. Ramón Alejandro Morillo Verdugo has worked at Hospital Pharmacy Seville since 2006. He has been an Associate Professor at University of Seville since 2011. He is also the Spanish national coordinator of the “MAPEX Project” from SEFH since 2014.

View all papers in this article collection